2014, BioTech, Health Policy and Pharmaceuticals

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2014

BioTech

Health Policy

Pharmaceuticals

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

OCTOBER 28, 2019

patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. Over one-half of Americans blame pharmaceutical companies as most responsible for the opioid crisis, followed by physicians, whom 39% of health consumers blame, and patients, whom 38% of people blame. Exacerbating U.S.

Pharmaceuticals

Pharmaceuticals Medical Billing Medicare Mental health

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Health Populi

MAY 8, 2019

Total patient OOP costs in 2018 reached $61 billion, up $2 bn from 2017, and $5 bn from 2014. Just under 9% of patients across all three health plan types had over $500 in OOP costs in 2018. This takes us from the pharma manufacturer’s perspective to the patient’s role in the Rx ecosystem.

Medicare

Medicare BioTech Pharmaceuticals Mental health

Connected Health Pulse

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Prescription Drug Costs In America Through the Patient Lens, via IQVIA, GoodRx and a New $2 Million Therapy

Stay Connected